| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the prevention and treatment of breast cancer-related lymphedema
|
Donahue, Paula M. C.
|
|
|
200 |
1 |
p. 1-14
|
artikel
|
| 2 |
Breast cancer survivorship and sexual dysfunction: a population-based cohort study
|
Chang, Chun-Pin
|
|
|
200 |
1 |
p. 103-113
|
artikel
|
| 3 |
Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors
|
Odai-Afotey, Ashley
|
|
|
200 |
1 |
p. 127-137
|
artikel
|
| 4 |
Clinical efficacy of PARP inhibitors in breast cancer
|
Pandya, Karan
|
|
|
200 |
1 |
p. 15-22
|
artikel
|
| 5 |
Clinical significance of microinvasive breast cancer across the different subtypes and human epidermal growth factor receptor 2 expression levels
|
Lee, Soo-Young
|
|
|
200 |
1 |
p. 47-61
|
artikel
|
| 6 |
Comparison of initial and sequential salvage brain-directed treatment in patients with 1–4 vs. 5–10 brain metastases from breast cancer (KROG 16–12)
|
Kim, Jae Sik
|
|
|
200 |
1 |
p. 37-45
|
artikel
|
| 7 |
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
|
Bychkovsky, Brittany L.
|
|
|
200 |
1 |
p. 73
|
artikel
|
| 8 |
Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)
|
Hershman, Dawn L.
|
|
|
200 |
1 |
p. 93-102
|
artikel
|
| 9 |
Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study
|
Xiao, Jinyu
|
|
|
200 |
1 |
p. 115-126
|
artikel
|
| 10 |
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
|
Bychkovsky, Brittany L.
|
|
|
200 |
1 |
p. 63-72
|
artikel
|
| 11 |
Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis
|
Nimbalkar, Vidya P.
|
|
|
200 |
1 |
p. 139-149
|
artikel
|
| 12 |
Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer
|
Sathe, Claire
|
|
|
200 |
1 |
p. 85-92
|
artikel
|
| 13 |
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
|
Altwegg, Kristin A.
|
|
|
200 |
1 |
p. 151-162
|
artikel
|
| 14 |
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer
|
Terman, Elizabeth
|
|
|
200 |
1 |
p. 75-83
|
artikel
|
| 15 |
The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer
|
Hu, Jiayue
|
|
|
200 |
1 |
p. 23-36
|
artikel
|
Tijdschrift beschrijving